Exploring the Role of Staphylococcus Aureus Toxins in Atopic Dermatitis

Imagem de Miniatura
Arquivos
art_YOSHIKAWA_Exploring_the_Role_of_Staphylococcus_Aureus_Toxins_in_2019.PDF (856.74 KB)
Citações na Scopus
44
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
Citação
TOXINS, v.11, n.6, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Atopic dermatitis (AD) is a chronic and inflammatory skin disease with intense pruritus and xerosis. AD pathogenesis is multifactorial, involving genetic, environmental, and immunological factors, including the participation of Staphylococcus aureus. This bacterium colonizes up to 30-100% of AD skin and its virulence factors are responsible for its pathogenicity and antimicrobial survival. This is a concise review of S. aureus superantigen-activated signaling pathways, highlighting their involvement in AD pathogenesis, with an emphasis on skin barrier disruption, innate and adaptive immunity dysfunction, and microbiome alterations. A better understanding of the combined mechanisms of AD pathogenesis may enhance the development of future targeted therapies for this complex disease.
Palavras-chave
Staphylococcus aureus, enterotoxins, atopic dermatitis, innate immunity, adaptive immunity, microbiome
URI
https://observatorio.fm.usp.br/handle/OPI/33070
Referências
  1. Ackermann L, 1998, IMMUNOLOGY, V94, P247, DOI 10.1046/j.1365-2567.1998.00508.x
  2. Auriemma M, 2013, EUR CYTOKINE NETW, V24, P37, DOI 10.1684/ecn.2013.0333
  3. Azimi Ehsan, 2017, Itch (Phila), V2, DOI 10.1097/itx.0000000000000005
  4. Baldry M, 2018, J INFECT DIS, V218, P1009, DOI 10.1093/infdis/jiy259
  5. Batista DIS, 2015, J EUR ACAD DERMATOL, V29, P1091, DOI 10.1111/jdv.12753
  6. Biedermann T, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00353
  7. Bin LH, 2012, J ALLERGY CLIN IMMUN, V130, P683, DOI 10.1016/j.jaci.2012.06.019
  8. Blicharz L, 2019, POSTEP DERM ALERGOL, V36, P11, DOI 10.5114/ada.2019.82821
  9. Boccardi D, 2017, MINERVA PEDIATR, V69, P373, DOI 10.23736/S0026-4946.16.04294-8
  10. Bratton DL, 1999, J ALLERGY CLIN IMMUN, V103, P895, DOI 10.1016/S0091-6749(99)70435-5
  11. Brauweiler AM, 2017, J INVEST DERMATOL, V137, P2030, DOI 10.1016/j.jid.2017.05.003
  12. Brauweiler AM, 2014, J INVEST DERMATOL, V134, P2114, DOI 10.1038/jid.2014.43
  13. Brauweiler AM, 2013, J ALLERGY CLIN IMMUN, V131, P421, DOI 10.1016/j.jaci.2012.10.030
  14. Breuer K, 2005, CLIN EXP ALLERGY, V35, P1088, DOI 10.1111/j.1365-2222.2005.02295.x
  15. Clowry J, 2019, J ALLERGY CLIN IMMUN, V143, P78, DOI 10.1016/j.jaci.2018.08.038
  16. COLE GW, 1986, ARCH DERMATOL, V122, P166, DOI 10.1001/archderm.122.2.166
  17. Coutanceau C, 2014, DERMATOLOGY, V229, P248, DOI 10.1159/000365075
  18. D'Auria E, 2016, ASIAN PAC J ALLERGY, V34, P98, DOI 10.12932/AP0732.34.2.2016
  19. De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259
  20. Titz TD, 2016, J EUR ACAD DERMATOL, V30, P2072, DOI 10.1111/jdv.13825
  21. dos Santos VG, 2017, INT J DERMATOL, V56, P630, DOI 10.1111/ijd.13537
  22. Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767
  23. Elias PM, 2009, CURR OPIN ALLERGY CL, V9, P437, DOI 10.1097/ACI.0b013e32832e7d36
  24. Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184
  25. Ezepchuk YV, 1996, J INVEST DERMATOL, V107, P603, DOI 10.1111/1523-1747.ep12583377
  26. Fassbender S, 2017, J INVEST DERMATOL, V137, P1802, DOI 10.1016/j.jid.2017.04.015
  27. Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700
  28. Hayashida S, 2011, J DERMATOL SCI, V61, P180, DOI 10.1016/j.jdermsci.2010.10.013
  29. Huang K, 2018, J DERMATOL SCI, V92, P272, DOI 10.1016/j.jdermsci.2018.11.010
  30. Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
  31. JORGENSEN J, 1987, ALLERGY, V42, P395, DOI 10.1111/j.1398-9995.1987.tb02227.x
  32. Kapitany A, 2017, ACTA DERM-VENEREOL, V97, P325, DOI 10.2340/00015555-2540
  33. Kasraie S, 2012, ALLERGY, V67, P41, DOI 10.1111/j.1398-9995.2011.02710.x
  34. Kasraie S, 2010, ALLERGY, V65, P712, DOI 10.1111/j.1398-9995.2009.02255.x
  35. Kedzierska A, 2005, ARCH IMMUNOL THER EX, V53, P63
  36. Kennedy EA, 2017, J ALLERGY CLIN IMMUN, V139, P166, DOI 10.1016/j.jaci.2016.07.029
  37. Kim BS, 2014, EUR J DERMATOL, V24, P186, DOI 10.1684/ejd.2014.2302
  38. Kissner TL, 2011, INNATE IMMUN-LONDON, V17, P451, DOI 10.1177/1753425910374092
  39. Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111
  40. Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111
  41. Krakauer T, 2013, TOXINS, V5, P1629, DOI 10.3390/toxins5091629
  42. Krogman A, 2017, HLA, V89, P20, DOI 10.1111/tan.12930
  43. Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976
  44. Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563
  45. Laborel-Preneron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141067
  46. Lee HW, 2013, ANN DERMATOL, V25, P173, DOI 10.5021/ad.2013.25.2.173
  47. Leung DYM, 2013, ALLERGOL INT, V62, P151, DOI 10.2332/allergolint.13-RAI-0564
  48. Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308
  49. Lin YT, 2000, ALLERGY, V55, P641, DOI 10.1034/j.1398-9995.2000.00523.x
  50. Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006
  51. Mandron M, 2008, J INVEST DERMATOL, V128, P882, DOI 10.1038/sj.jid.5701112
  52. Mandron M, 2006, J ALLERGY CLIN IMMUN, V117, P1141, DOI 10.1016/j.jaci.2005.12.1360
  53. Matejuk A, 2018, ARCH IMMUNOL THER EX, V66, P45, DOI 10.1007/s00005-017-0477-3
  54. Matsuo K, 2018, J INVEST DERMATOL, V138, P1764, DOI 10.1016/j.jid.2018.02.027
  55. Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016
  56. Minai-Fleminger Y, 2014, CLIN EXP ALLERGY, V44, P1335, DOI 10.1111/cea.12422
  57. Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729
  58. Myles IA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120608
  59. Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680
  60. Nakatsuji T, 2016, J INVEST DERMATOL, V136, P2192, DOI 10.1016/j.jid.2016.05.127
  61. Niebuhr M, 2008, ALLERGY, V63, P728, DOI 10.1111/j.1398-9995.2008.01721.x
  62. Niebuhr M, 2014, ALLERGY, V69, P1058, DOI 10.1111/all.12428
  63. Niebuhr M, 2009, ALLERGY, V64, P1580, DOI 10.1111/j.1398-9995.2009.02050.x
  64. Niebuhr M, 2015, EXP DERMATOL, V24, P381, DOI 10.1111/exd.12674
  65. Niebuhr M, 2011, EXP DERMATOL, V20, P468, DOI 10.1111/j.1600-0625.2011.01277.x
  66. Niebuhr M, 2010, CURR OPIN ALLERGY CL, V10, P463, DOI 10.1097/ACI.0b013e32833e3163
  67. Oliveira D, 2018, TOXINS, V10, DOI 10.3390/toxins10060252
  68. Orfali RL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25125-0
  69. Orfali RL, 2009, EXP DERMATOL, V18, P628, DOI 10.1111/j.1600-0625.2009.00842.x
  70. Paller AS, 2019, J ALLERGY CLIN IMMUN, V143, P26, DOI 10.1016/j.jaci.2018.11.015
  71. Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222
  72. Parlet CP, 2019, TRENDS MICROBIOL, V27, P497, DOI [10.1016/j.tim.2019.01.008, 10.1016/j.tim.2019.01.003]
  73. Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047
  74. Roesner LM, 2016, EXPERT REV CLIN IMMU, V12, P787, DOI 10.1586/1744666X.2016.1165093
  75. Ruzicka T, 2017, NEW ENGL J MED, V376, P826, DOI 10.1056/NEJMoa1606490
  76. Saeed K, 2014, CURR OPIN INFECT DIS, V27, P130, DOI 10.1097/QCO.0000000000000046
  77. Salava A, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-33
  78. Saloga J, 1996, J INVEST DERMATOL, V106, P982, DOI 10.1111/1523-1747.ep12338479
  79. Schommer NN, 2013, TRENDS MICROBIOL, V21, P660, DOI 10.1016/j.tim.2013.10.001
  80. Shi BC, 2016, J ALLERGY CLIN IMMUN, V138, P1233, DOI 10.1016/j.jaci.2016.04.053
  81. Simpson EL, 2018, J INVEST DERMATOL, V138, P2224, DOI 10.1016/j.jid.2018.03.1517
  82. Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033
  83. Stoll H, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00321
  84. Syed AK, 2015, INFECT IMMUN, V83, P3428, DOI 10.1128/IAI.00401-15
  85. Tam K, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0039-2018
  86. Tanaka A, 2015, ANN ALLERG ASTHMA IM, V115, P191, DOI 10.1016/j.anai.2015.06.017
  87. Triplett KD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37951-3
  88. Tuffs SW, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020053
  89. Turner NA, 2019, NAT REV MICROBIOL, V17, P203, DOI 10.1038/s41579-018-0147-4
  90. Wedi B, 2002, J ALLERGY CLIN IMMUN, V109, P477, DOI 10.1067/mai.2002.121702
  91. Wehner J, 2001, BRIT J DERMATOL, V145, P302, DOI 10.1046/j.1365-2133.2001.04352.x
  92. Werfel T, 2016, J ALLERGY CLIN IMMUN, V138, P336, DOI 10.1016/j.jaci.2016.06.010
  93. Wichmann K, 2009, BRIT J DERMATOL, V161, P300, DOI 10.1111/j.1365-2133.2009.09229.x
  94. Yu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039032
  95. Zhang XP, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00109

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/56